Κonstantinos Laschos

Author

Hospital Agioi Anargyroi

Also Known As

KONSTANTINOS LASCHOS, Konstantinos Laschos, Κonstantinos Laschos

Publications

347

Citations

H-Index

Concepts

All Affiliations

Hospital Agioi Anargyroi National and Kapodistrian University of Athens Hippocration General Hospital Metropolitan Hospital Papageorgiou General Hospital

ΚL

About

Κonstantinos Laschos is an author at Hospital Agioi Anargyroi specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	187
2	Pathology	3	3	63
3	Health Sciences	2	2	48
4	Immunology	2	2	138
5	Gastroenterology	1	1	18

Κonstantinos Laschos

Publications

278

Citations

H-Index

Page 1

	Year	Citations
Anti-PD1/PDL1 induced psoriasis Dimitra Voudouri, Vasiliki Nikolaou, Κonstantinos Laschos, Current Problems in Cancer Autoimmune DiseaseImmunologyClinical DermatologyPharmacotherapyDermatology	2017	107
Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents Ourania Nicolatou‐Galitis, Erofili Papadopoulou, Emmanouil Vardas, Oral Diseases	2020	65
Erythropoiesis stimulating agents are associated with reduced survival in patients with multiple myeloma Eirini Katodritou, Evgenia Verrou, Christina Hadjiaggelidou, American Journal of Hematology ImmunologyPathologyAplastic AnemiaMyeloid NeoplasiaHematological Malignancy	2008	31
Gastrointestinal Stromal Tumors (GIST): A Prospective Analysis and an Update on Biomarkers and Current Treatment Concepts Anna Koumarianou, Panagiota Economopoulou, Panagiotis Katsaounis, Biomarkers in Cancer Surgical OncologyCancer ManagementGastroenterologyPathologyTumor Biology	2015	18
Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: clinical outcomes from a retrospective clinical study Loukas Kontovinis, Κonstantinos Laschos, Alexandra Karadimou, Medical Oncology UrologyGenitourinary CancerMedicineClinical OutcomesSequential Treatment	2011	17
AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer George Pentheroudakis, Vassiliki Kotoula, Georgia-Angeliki Koliou, Clinical Colorectal Cancer Single-arm StudyAflibercept MaintenanceGastrointestinal OncologyMedicineCancer Management	2018	14
Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer Dimitra Ioanna Lampropoulou, Gerasimos Aravantinos, Hector Katifelis, Cancer Biomarkers	2019	14
Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia Giannis Mountzios, Gerasimos Aravantinos, Zoi Alexopoulou, Molecular and Clinical Oncology	2015	12

Page 1